These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30598545)

  • 1. Targeted delivery of nitric oxide via a 'bump-and-hole'-based enzyme-prodrug pair.
    Hou J; Pan Y; Zhu D; Fan Y; Feng G; Wei Y; Wang H; Qin K; Zhao T; Yang Q; Zhu Y; Che Y; Liu Y; Cheng J; Kong D; Wang PG; Shen J; Zhao Q
    Nat Chem Biol; 2019 Feb; 15(2):151-160. PubMed ID: 30598545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of nitric oxide released from beta-Gal-NONOate activation by beta-galactosidase and its activity against Escherichia coli.
    Chen C; Shi YQ; Song J; Qi QS; Gu L; Wang PG
    Biol Pharm Bull; 2006 Jun; 29(6):1239-41. PubMed ID: 16755024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy.
    Huang H; Qian M; Liu Y; Chen S; Li H; Han Z; Han ZC; Chen XM; Zhao Q; Li Z
    Elife; 2023 Sep; 12():. PubMed ID: 37695201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Endocellulase-Triggered NO Targeted-Release Enzyme-Prodrug Therapy System and Its Application in Ischemia Injury.
    He B; Zhang Y; Liu H; Tang M; Yang K; Cheng S; Shen J; Wei Y; Deng W; Zhao Q; Yang GY
    Adv Healthc Mater; 2024 Jun; ():e2401599. PubMed ID: 38973653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity.
    Chen C; Shi Y; Li S; Qi Q; Gu L; Song J; Wang PG
    Arch Pharm (Weinheim); 2006 Jul; 339(7):366-71. PubMed ID: 16783837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-functionalized vascular grafts catalyze in-situ release of nitric oxide from exogenous NO prodrug.
    Wang Z; Lu Y; Qin K; Wu Y; Tian Y; Wang J; Zhang J; Hou J; Cui Y; Wang K; Shen J; Xu Q; Kong D; Zhao Q
    J Control Release; 2015 Jul; 210():179-88. PubMed ID: 26004323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver.
    Saavedra JE; Billiar TR; Williams DL; Kim YM; Watkins SC; Keefer LK
    J Med Chem; 1997 Jun; 40(13):1947-54. PubMed ID: 9207935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury.
    Bahnson ES; Kassam HA; Moyer TJ; Jiang W; Morgan CE; Vercammen JM; Jiang Q; Flynn ME; Stupp SI; Kibbe MR
    Antioxid Redox Signal; 2016 Mar; 24(8):401-18. PubMed ID: 26593400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed delivery of nitric oxide to cancers.
    Sharma K; Chakrapani H
    Nitric Oxide; 2014 Dec; 43():8-16. PubMed ID: 25124221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme Mimics for the Catalytic Generation of Nitric Oxide from Endogenous Prodrugs.
    Yang T; Zelikin AN; Chandrawati R
    Small; 2020 Jul; 16(27):e1907635. PubMed ID: 32372556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroreductase-activated nitric oxide (NO) prodrugs.
    Sharma K; Sengupta K; Chakrapani H
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5964-7. PubMed ID: 24050886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide.
    Winther AK; Fejerskov B; Ter Meer M; Jensen NBS; Dillion R; Schaffer JE; Chandrawati R; Stevens MM; Schultze Kool LJ; Simonsen U; Zelikin AN
    ACS Appl Mater Interfaces; 2018 Apr; 10(13):10741-10751. PubMed ID: 29570264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE
    Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gasotransmitter delivery via self-assembling peptides: Treating diseases with natural signaling gases.
    Qian Y; Matson JB
    Adv Drug Deliv Rev; 2017 Feb; 110-111():137-156. PubMed ID: 27374785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies.
    Han S; Quach T; Hu L; Wahab A; Charman WN; Stella VJ; Trevaskis NL; Simpson JS; Porter CJ
    J Control Release; 2014 Mar; 177():1-10. PubMed ID: 24398334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interaction of β-galactosyl-pyrrolidinyl diazeniumdiolate with cisplatin against three tumor cells.
    Deng L; Zhang E; Chen C
    Arch Pharm Res; 2013 May; 36(5):619-25. PubMed ID: 23494564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide redox species exert differential permeability effects on the blood-brain barrier.
    Boje KM; Lakhman SS
    J Pharmacol Exp Ther; 2000 May; 293(2):545-50. PubMed ID: 10773027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-galactosyl-pyrrolidinyl diazeniumdiolate: an efficient tool to investigate nitric oxide functions on promoting cell death.
    Chen C; Zhang E
    Appl Microbiol Biotechnol; 2013 Aug; 97(16):7377-85. PubMed ID: 23801048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
    Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
    Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy.
    Yin M; Tan S; Bao Y; Zhang Z
    J Control Release; 2017 Jul; 258():108-120. PubMed ID: 28522191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.